IP Library › Assignment 054866/0449
Patent Assignment
Reel/Frame 054866/0449

Change of Name

Recorded: 2020-12-29 Pages: 8
Assignor
PDX PHARMACEUTICALS, LLC
Executed: 2019-11-14
Assignee
PDX PHARMACEUTICALS, INC.
3303 S BOND AVE., 13TH FLOOR, PORTLAND, OREGON, 97239
Covered Property (1)
Therapeutic Constructs for Co-Delivery of Mitotic Kinase Inhibitor and Immune Checkpoint Inhibitor
Application: 17/023,311 →
Publication: US 2021/0030679
Related Assignments (4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 12, 2020
From: NGAMCHERDTRAKUL, WORAPOL
To: PDX PHARMACEUTICALS, LLC
Reel/Frame 054353/0529 →
Corrective Assignment to Correct the Assignee's Name Previously Recorded at Reel: 054353 Frame: 0529. Assignor(S) Hereby Confirms the Assignment . Nov 23, 2020
From: NGAMCHERDTRAKUL, WORAPOL
To: PDX PHARMACEUTICALS, INC.
Reel/Frame 054503/0083 →
Assignment of Assignor's Interest Dec 3, 2020
From: YANTASEE, WASSANA; REDA, MOATAZ
To: OREGON HEALTH & SCIENCE UNIVERSITY
Reel/Frame 054530/0300 →
Confirmatory License Oct 17, 2023
From: OREGON HEALTH & SCIENCE UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 065257/0261 →